Top

Clinical and Translational Oncology

Published in:

01-10-2007 | Educational Series

Pharmacodynamics: biological activity of targeted therapies in clinical trials

Authors: F. Rojo, A. Dalmases, J. M. Corominas, J. Albanell

Published in: Clinical and Translational Oncology | Issue 10/2007

Title: Pharmacodynamics: biological activity of targeted therapies in clinical trials
Authors: F. Rojo
A. Dalmases
J. M. Corominas
J. Albanell
Publication date: 01-10-2007
Publisher: Springer Milan
Published in: Clinical and Translational Oncology / Issue 10/2007
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI: https://doi.org/10.1007/s12094-007-0116-2

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

ACC 2024 Congress

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 10/2007

Can the clinical outcome in state II colon carcinomas be predicted by determination of molecular marker expression?

The world of chronos

Impact of erythropoietin treatment on the quality of life of oncologic patients

Sorafenib TARGET Trial results in Spanish patients

Glucagonoma with two pancreatic masses and pulmonary metastases as debut of MEN-1

Intrahepatic mucinous biliary cystadenoma

Keynote webinar | Spotlight on antibody–drug conjugates in cancer